BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
FOXP1
,
T cell differentiation
,
Diabetes mellitus
,
Leukocyte
,
Laryngoscope
,
Tamoxifen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
NRAS
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Colon mucosa
Ileum mucosa
Thymus gland
Rectum colon
Skin
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Binimetinib for the treatment of NRAS-mutant melanoma.
Detecting N-RAS Q61R Mutated Thyroid Neoplasias by Immunohistochemistry.
N-RAS expression in patients with salivary adenoid cystic carcinoma: association with clinicopatholo…
Genotype and phenotype spectrum of NRAS germline variants.
Treatment of NRAS-mutant melanoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
HL-085 in NRAS-mutated Advanced Melanoma
A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors
MEK and Autophagy Inhibition in Metastatic/Locally Advanced, Unresectable Neuroblastoma RAS (NRAS) M…
Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Met…
MEK Inhibitor FCN-159 To Treat Advanced Melanoma With NRAS-aberrant (Ia) and NRAS-mutant (Ib)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ